A $400B pharma merger, a GLP-1 breakthrough and a fight over 340B — plus HHS’s funding cuts.
August 5, 2026

1. AstraZeneca weighs $400B Bristol Myers merger Full story

2. GLP-1 therapies may enable personalized obesity care Full story

3. 2 KPIs drive readmission outcomes. Both can be managed in real time — see how here.

 

4. HHS to stop funding ‘dangerous’ life sciences research Full story

5. FDA panel backs melanoma therapy after 2 rejections Full story

6. Where do clinicians’ hours actually go? A hard look at lost bedside time here.

 

7. GLP-1s and pregnancy: 5 things to know Full story

8. KFF: Who wins under CMS’ 340B proposal? Full story

Becker’s Learning Opportunities

9. Ochsner Health cut unidentified procedural spend from 9% to 5%. See how here.

10. Medication affordability is now an enterprisewide priority. See what’s changing, here.

11. Physician burnout costs $4B+ a year. 19,000 physicians reveal what’s working here

12. Becker’s resources don’t stop here — explore more webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker’s Hospital Review, A Becker’s Healthcare Publication